NCT02160808View on ClinicalTrials.gov

Secretin Infusion to Prevent Pancreatic Leaks Following Pancreatic Resection

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

September 21, 2019

Study Completion Date

September 21, 2019

Conditions
Injury of Body of Pancreas
Interventions
DRUG

Secretin

Drug to stimulate pancreatic secretion

DRUG

Placebo

Trial Locations (1)

03756

Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT02160808 - Secretin Infusion to Prevent Pancreatic Leaks Following Pancreatic Resection | Biotech Hunter | Biotech Hunter